Open AccessEfficacy of omarigliptin, once-weekly dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes
Author(s) -
Eiji Kawasaki,
Yuko Nakano,
Takahiro Fukuyama,
Aira Uchida,
Yoko Sagara,
Hidekazu Tamai,
Masayuki Tojikubo,
Yuji Hiromatsu,
Nobuhiko Koga
Publication year - 2021
Publication title -
world journal of diabetes
Language(s) - English
Resource type - Journals
ISSN - 1948-9358
DOI - 10.4239/wjd.v12.i12.2087
Subject(s) - vildagliptin , linagliptin , sitagliptin , medicine , glycemic , type 2 diabetes , dipeptidyl peptidase 4 inhibitor , dipeptidyl peptidase 4 , diabetes mellitus , type 2 diabetes mellitus , gastroenterology , pharmacology , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom